Sharps Technology (NASDAQ:STSS) Issues Earnings Results, Misses Expectations By $2.21 EPS

Sharps Technology (NASDAQ:STSS) announced its quarterly earnings results on Thursday. The company reported ($2.87) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($2.21), Zacks reports.

Sharps Technology Trading Down 72.3 %

STSS stock opened at $0.04 on Friday. The firm has a market capitalization of $232,565.40, a price-to-earnings ratio of -0.01 and a beta of 1.47. Sharps Technology has a 1 year low of $0.04 and a 1 year high of $18.15. The company has a 50-day moving average of $0.49.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.